ArriVent BioPharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVBP and other ETFs, options, and stocks.About AVBP
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
AVBP Key Statistics
Stock Snapshot
With a market cap of 821.96M, ArriVent BioPharma(AVBP) trades at $16.66. The stock has a price-to-earnings ratio of -4.53.
During the trading session on 2026-10-17, ArriVent BioPharma(AVBP) shares reached a daily high of $17.23 and a low of $16.49. At a current price of $16.66, the stock is +1.1% higher than the low and still -3.3% under the high.
Trading activity shows a volume of 1.33M, compared to an average daily volume of 3.55M.
Over the past 52 weeks, ArriVent BioPharma(AVBP) stock has traded between a high of $35.83 and a low of $11.36.
Over the past 52 weeks, ArriVent BioPharma(AVBP) stock has traded between a high of $35.83 and a low of $11.36.
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.